Silver Sulfadiazine: an Antibacterial Agent for Topical use in Burns

References

• Akahane T., Tsukada S. Electron-microscopic observation on silver deposition in burn wounds treated with silver sulfadiazine cream. Burns 1982; 8: 271
   Google Scholar
• Baar S. The effect of silver compounds on the metabolism of human red cells. Burns 1975; 2: 58
   Google Scholar
• Babb J. R., Bridges K., Jackson D. M., Lowbury E. J. L., Ricketts C. R. Topical chemoprophylaxis: trials in silver phosphate chlorhexidine, silver sulpha-diazine and povidone iodine preparations. Burns 1977; 3: 65
   Google Scholar
• Bach J., Draslov B., Jølash;rgensen B. Positioning, splinting, and pressure management of the burned hand—a method. Scand J Plast Reconstr Surg 1984; 18: 145
   PubMed Web of Science ®Google Scholar
• Baxter C. R. Topical use of 1% silver sulfadiazine. Contemporary burn management. 1st edn., H C. Polk, Jr, H H. Stone. Little, Brown & Co, Boston 1971; 217–225
   Google Scholar
• de Boer P., Collinson P. O. The use of silver sulphadiazine occlusive dressings for finger-tip injuries. J Bone Joint Surg (Br) 1981; 63-B: 545
   Google Scholar
• Burleson R., Eiseman B. Effect of skin dressings and topical antibiotics on healing of partial thickness skin wounds in rats. Surg Gynecol Obstet 1973; 136: 958
   PubMedGoogle Scholar
• Caffee H. H., Bingham H. G. Leukopenia and silver sulfadiazine. J Trauma 1982; 22: 586
   PubMedGoogle Scholar
• Carr H. S., Wlodkowski T. J., Rosenkranz H. S. Silver sulfadiazine: In vitro antibacterial activity. Antimicrob Ag Chemother 1973; 4: 585
   PubMed Web of Science ®Google Scholar
• Chan C. K., Jarrett F., Moylan J. A. Acute leukopenia as an allergic reaction to silver sulfadiazine in burn patients. J Trauma 1976; 16: 395
   PubMedGoogle Scholar
• Chang T.-W, Weinstein L. In vitro activity of silver sulfadiazine against Herpesvirus hominis. J Infect Dis 1975; 132: 79
   PubMedGoogle Scholar
• Coward J. E., Carr H. S., Rosenkranz H. S. Silver sulfadiazine: Effect on the ultrastructure of Pseudomonas aeruginosa. Antimicrob Ag Chemother 1973a; 3: 621
   PubMed Web of Science ®Google Scholar
• Coward J. E., Carr H. S., Rosenkranz H. S. Silver sulfadiazine: Effect on growth and ultrastructure of Staphylococci. Chemotherapy 1973b; 19: 348
   PubMedGoogle Scholar
• Coward J. E., Rosenkranz H. S. Electron microscopic appearance of silver sulfadiazine-treated Enterobacter cloacae. Chemotherapy 1975; 21: 231
   PubMedGoogle Scholar
• Denny A. D., Twomey J. A., Hitchcock C. R. A preliminary report on the spray application of topical silver sulfadiazine to burn wounds. J Trauma 1978; 18: 730
   PubMedGoogle Scholar
• Dressler D. P, Skornik W. A. Silver sulfadiazine and sulfamylon cream in the burned rat model: A comparative evaluation. Surgery 1970; 67: 644
   PubMedGoogle Scholar
• Fox C. L., Jr. Silver sulfadiazine—a new topical therapy for Pseudomonas in burns. Therapy of Pseudomonas infection in burns. Arch Surg 1968; 96: 184
   PubMed Web of Science ®Google Scholar
• Fox C. L., Jr. Topical therapy and the development of silver sulfadiazine. Surg Gynecol Obstet 1983; 157: 82
   PubMedGoogle Scholar
• Fox C. L., Jr, Modak S. M. Mechanism of silver sulfadiazine action on burn wound infections. Antimicrob Ag Chemother 1974; 5: 582
   PubMed Web of Science ®Google Scholar
• Fox C. L., Jr, Modak S. M., Stanford J. W. Zinc sulfadiazine for topical therapy of Pseudomonas infection in burns. Surg Gynecol Obstet 1976; 142: 553
   PubMedGoogle Scholar
• Fox C. L., Modak S. M., Stanford J. W. Cerium sulphadiazine as a topical agent for burn wound infections: a comparison with silver sulphadiazine and zinc sulphadiazine. Burns 1978; 4: 233
   Web of Science ®Google Scholar
• Fox C. L., Jr, Modak S. M., Stanford J. W., Fox P. L. Metal sulfonamides as antibacterial agents in topical therapy. Scand J Plast Reconstr Surg 1979; 13: 89
   PubMed Web of Science ®Google Scholar
• Fox C. L., Parsa M. H. Treatment of infected burns and wounds with zinc sulfadiazine. Iran J Surg 1979; 2: 113
   Google Scholar
• Fox C. L., Jr, Rappole B. W., Stanford W. Control of Pseudomonas infection in burns by silver sulfadiazine. Surg Gynecol Obstet 1969; 128: 1021
   PubMedGoogle Scholar
• Fox C. L., Jr, Sampath A. C, Stanford J. W. Virulence of Pseudomonas infection in burned rats and mice. Comparative efficacy of silver sulfadiazine and mafenide. Arch Surg 1970; 101: 508
   PubMedGoogle Scholar
• Fraser G. L., Beaulieu J. T. Leukopenia secondary to sulfadiazine silver. JAMA 1979; 241: 1928
   PubMedGoogle Scholar
• Fraser-Moodie A., Nancarrow J. Neutropenia and thrombocytopenia in burns. Burns 1977; 3: 235
   Google Scholar
• Gayle W. E., Jr, Mayhall C. G., Lamb V. A., Apollo E., Haynes B. W., Jr. Resistant Enterobacter cloacae in a burn center: The ineffectiveness of silver sulfadiazine. J Trauma 1978; 18: 317
   PubMedGoogle Scholar
• Heggers J. P., Ko F., Robson M. C. Cerium nitrate/silver sulphadiazine: synergism or antagonism as determined by minimum inhibitory concentration. Burns 1979; 5: 308
   Google Scholar
• Holder I. A. In vitro inactivation of silver sulphadiazine by the addition of cerium salts. Burns 1982; 8: 274
   Google Scholar
• Jarrett F., Ellerbe S., Demling R. Acute leukopenia during topical burn therapy with silver sulfadiazine. Am J Surg 1978; 135: 818
   PubMedGoogle Scholar
• Karuna Sagar I., Nagesha C. N., Rao P. G. Effectiveness of zinc sulphadiazine, zinc sulphate and silver sulphadiazine in the topical therapy of pseudomonas infection in burns. Burns 1979; 6: 131
   Google Scholar
• Kiker R. G., Carvajal H. F., Mlcak R. P., Larson D. L. A controlled study of the effects of silver sulfadiazine on white blood cell counts in burned children. J Trauma 1977; 17: 835
   PubMedGoogle Scholar
• Krizek T. J., Cossman D. V. Experimental burn wound sepsis: variations in response to topical agents. J Trauma 1972; 12: 553
   PubMedGoogle Scholar
• Lawrence J. C. An experimental and clinical evaluation of a tulle gras dressing medicated with silver sulphadiazine. Burns 1977; 3: 186
   Google Scholar
• Lazare R., Watson P. A., Winter G. D. Distribution and excretion of silver sulphadiazine applied to scalds in the pig. Burns 1974; 1: 57
   Google Scholar
• Lloyd J. R. Improved management of skin graft donor sites with silver sulfadiazine dressings. Arch Surg 1974; 108: 561
   PubMedGoogle Scholar
• Lowbury E. J. L., Babb J. R., Bridges K., Jackson D. M. Topical chemoprophylaxis with silver sulphadiazine and silver nitrate chlorhexidine creams: emergence of sulphonamide-resistant Gram-negative bacilli. Br Med J 1976; 1: 493
   PubMedGoogle Scholar
• Lowbury E. J. L., Jackson D. M., Lilly H. A., Bull J. P., Cason J. S., Davies J. W. L., Ford P. M. Alternative forms of local treatment for burns. Lancet 1971a; II: 1105
   Google Scholar
• Lowbury E. J. L., Jackson D. M., Ricketts C. R., Davis B. Topical chemoprophylaxis for burns: trials of creams containing silver sulphadiazine and trimethoprim. Injury 1971b; 3: 18
   PubMedGoogle Scholar
• Modak S. M., Fox C. L., Jr. Binding of silver sulfadiazine to the cellular components of Pseudomonas aeruginosa. Biochem Pharmacol 1973; 22: 2391
   PubMed Web of Science ®Google Scholar
• ModaK S. M, Fox C. L., Jr. Sulfadiazine silverresistant Pseudomonas in burns. New topical agents. Arch Surg 1981; 116: 854
   PubMedGoogle Scholar
• Monafo W. W., Ayvazian V. H. Topical therapy. Surg Clin North Am 1978; 58: 1157
   PubMedGoogle Scholar
• Monafo W. W., Ayvazian V. H., Skinner A. M. Control of infection in major burn wounds by cerium nitrate/silver sulphadiazine. Burns 1977; 3: 104
   Google Scholar
• Moncrief J. A. Burns. New Engl J Med 1973; 288: 444
   PubMedGoogle Scholar
• Munster A. M., Helvig E., Rowland S. Cerium nitrate-silver sulfadiazine cream in the treatment of burns: A prospective evaluation. Surgery 1980; 88: 658
   PubMed Web of Science ®Google Scholar
• Nagesha C. N., Karuna Sagar I. In vitro activity of sulfadiazine compounds of zinc and silver. Arch Surg 1978; 113: 906
   PubMedGoogle Scholar
• Nathan P., Law E. J., Murphy D. F., MacMillan B. G. A laboratory method for selection of topical antimicrobial agents to treat infected burn wounds. Burns 1978; 4: 177
   Web of Science ®Google Scholar
• Nølash;rmølash;lle E., Storm H., Kalaja E. Five years experience with the air-fluidized bed in the care of burned patients. Scand J Plast Reconstr Surg 1984; 18: 149
   PubMedGoogle Scholar
• Ollstein R. N., Symonds F. C., Crikelair G. F., Pelle L. Alternate case study of topical sulfamylon and silver sulfadiazine in burns. Plast Reconstr Surg 1971; 48: 311
   PubMedGoogle Scholar
• Owens C. J., Yarbrough I D. R., II, Brackett N. C., Jr. Nephrotic syndrome following topically applied sulfadiazine silver therapy. Arch Intern Med 1974; 134: 332
   PubMedGoogle Scholar
• Pegg S. P., Ramsay K., Meldrum L., Laundy M. Clinical comparison of maphenide and silver sulphadiazine. Scand J Plast Reconstr Surg 1979; 13: 95
   PubMed Web of Science ®Google Scholar
• Pruitt B. A., Jr, Curreri P. W. The burn wound and its care. Arch Surg 1971; 103: 461
   PubMedGoogle Scholar
• Robb E. C., Nathan P. Control of experimental burn wound infections: Comparative delivery of the antimicrobial agent (silver sulfadiazine) either from a cream base or from a solid synthetic dressing. J Trauma 1981; 21: 889
   PubMedGoogle Scholar
• Roe E. A., Jones R. J. Leucocyte responses of burned mice given mixed Gram-negative infections and treated topically with creams containing silver compounds. Burns 1977; 3: 72
   Google Scholar
• Rosenkranz H. S. A synergistic effect between cerium nitrate and silver sulphadiazine. Burns 1979; 5: 278
   Google Scholar
• Rosenkranz H. S., Carr H. S. The determination of the susceptibility of bacterial isolates to silver sulfadiazine. Chemotherapy 1978; 24: 143
   PubMedGoogle Scholar
• Rosenkranz H. S., Coward J. E., Wlodkowski T. J., Carr H. S. Properties of silver sulfadiazine-resistant Enterobacter cloacae. Antimicrob Ag Chemother 1974; 5: 199
   PubMedGoogle Scholar
• Saffer L. D., Rodeheaver G. T., Hiebert J. M., Edlich R. F. In vivo and in vitro antimicrobial activity of silver sulfadiazine and cerium nitrate. Surg Gynecol Obstet 1980; 151: 232
   PubMedGoogle Scholar
• Salisbury R. E., Bevin A. G., Steinkraus G. E., Enterline D. S. Burn wound sepsis: Effect of delayed treatment with topical chemotherapy on survival. J Trauma 1980; 20: 120
   PubMed Web of Science ®Google Scholar
• Sano S., Fujimori R., Takashima M, Itokawa Y. Absorption, excretion and tissue distribution of silver sulphadiazine. Burns 1982; 8: 278
   Google Scholar
• Skornik W. A., Dressler D. P. Topical antisepsis studies in the burned rat. Arch Surg 1971; 103: 469
   PubMedGoogle Scholar
• Snelling C. F. T., Ronald A. R., Waters W. R., Yaworski D. S., Drulak K., Sunderland M. Comparison of silver sulfadiazine and gentamicin for topical prophylaxis against burn wound sepsis. Can Med Assoc J 1978; 119: 466
   PubMedGoogle Scholar
• Speck W. T., Rosenkranz H. S. Activity of silver sulphadiazine against dermatophytes. Lancet 1974; II: 895
   Google Scholar
• Stanford W., Rappole B. W., Fox C. L., Jr. Clinical experience with silver sulfadiazine, a new topical agent for control of Pseudomonas infections in burns. J Trauma 1969; 9: 377
   PubMedGoogle Scholar
• Sykes P. J., Bailey B. N. Treatment of hand burns with occlusive bags: a comparison of 3 methods. Burns 1976; 2: 162
   Google Scholar
• Valente P., Axelrod J. L. Acute leukopenia associated with silver sulfadiazine therapy. J Trauma 1978; 18: 146
   PubMedGoogle Scholar
• Wlodkowski T. J., Rosenkranz H. S. Antifungal activity of silver sulphadiazine. Lancet 1973; II: 739
   Google Scholar